Issued Patents 2022
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11530196 | Pyrimidine compound acting on EGFR and ERBB2 | Lu Zhang, Xile LIU, Lihong Hu, Wen Jiang, Jian Li +1 more | 2022-12-20 |
| 11465986 | Crystal form of c-MET inhibitor and salt form thereof and preparation method therefor | Xiongbin XU, Gang Li, Ting YAO, Kun Wang, Lihong Hu | 2022-10-11 |
| 11459323 | Monocyclic β-lactam compound for treating bacterial infection | Lianghu Gu, Wei LUO, Zhigang Huang, Cheng LI, Shuhui CHEN | 2022-10-04 |
| 11453667 | Pyridone-pyrimidine derivative acting as KRASG12C mutein inhibitor | Yaxian Cai, Zhaobing Xu, Hailong Yang, Shiqi Han, Guoping HU +3 more | 2022-09-27 |
| 11390625 | Aryl-phosphorus-oxygen compound as EGFR kinase inhibitor | Lingyun WU, Xile LIU, Shuhui CHEN, Lihong Hu, Lele ZHAO +5 more | 2022-07-19 |
| 11358950 | SMAC mimetics used as IAP inhibitors and use thereof | Yingchun Liu, Zhaobing Xu, Lihong Hu, Xingxun Zhu, Guoping HU +2 more | 2022-06-14 |
| 11261196 | Salt serving as AKT inhibitor and crystal thereof | Gang Li, Lun Lu, Qingqing Lu, Lihong Hu | 2022-03-01 |
| 11236112 | Crystal form and salt form of TGF-βRI inhibitor and preparation method therefor | Lifang Wu, Huijun HE, Jianyu LU, Lihong Hu, Weidong Li +3 more | 2022-02-01 |